Effects of Insulin on Hypotension and Sarcopenia

NCT03248271 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-01-12

No results posted yet for this study

Summary

In this study investigator's aim to determine the impact of insulin therapy on hypotension and sarcopenia

Conditions

Interventions

DRUG

Insulin Lispro

Insulin

Sponsors & Collaborators

  • Kenneth Madden

    lead OTHER

Principal Investigators

  • Madden M Kenneth, MD · University of British Columbia/Gerontology Research Lab

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-01
Primary Completion
2023-01-10
Completion
2023-01-10

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03248271 on ClinicalTrials.gov